标题
Roles of Glutamate Receptors in Parkinson’s Disease
作者
关键词
-
出版物
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
Volume 20, Issue 18, Pages 4391
出版商
MDPI AG
发表日期
2019-09-09
DOI
10.3390/ijms20184391
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Prognosis and Neuropathologic Correlation of Clinical Subtypes of Parkinson Disease
- (2019) Eduardo De Pablo-Fernández et al. JAMA Neurology
- Effect of mGluR7 on proliferation of human embryonic neural stem cells
- (2019) Jing Zhang et al. MEDICINE
- Effect and mechanism of mGluR6 on the biological function of rat embryonic neural stem cells
- (2019) Jing Zhang et al. BIOSCIENCE BIOTECHNOLOGY AND BIOCHEMISTRY
- Extracellular mild acidosis decreases the Ca2+ permeability of the human NMDA receptors
- (2019) Simona Plutino et al. CELL CALCIUM
- Pathophysiological clues to therapeutic applications of glutamate mGlu5 receptor antagonists in levodopa-induced dyskinesia
- (2019) Shayan Pourmirbabaei et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Effects of exercise on mGluR-mediated glutamatergic transmission in the striatum of hemiparkinsonian rats
- (2019) Kaixuan Shi et al. NEUROSCIENCE LETTERS
- The levels of the NMDA receptor co-agonist D-serine are reduced in the substantia nigra of MPTP-lesioned macaques and in the cerebrospinal fluid of Parkinson’s disease patients
- (2019) Tommaso Nuzzo et al. Scientific Reports
- Metabotropic glutamate receptors: targets for neuroprotective therapies in Parkinson disease
- (2018) Gunasingh J Masilamoni et al. CURRENT OPINION IN PHARMACOLOGY
- Pharmacokinetics and brain uptake study of novel AMPA receptor antagonist perampanel in SD rats using a validated UHPLC-QTOF-MS method
- (2018) David Paul et al. JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS
- Altered mGluR5 binding potential and glutamine concentration in the 6-OHDA rat model of acute Parkinson's disease and levodopa-induced dyskinesia
- (2018) Melissa Crabbé et al. NEUROBIOLOGY OF AGING
- Electrical stimulation or MK-801 in the inferior colliculus improve motor deficits in MPTP-treated mice
- (2018) L. Melo-Thomas et al. NEUROTOXICOLOGY
- Neuropathology of Parkinson disease
- (2018) Dennis W. Dickson PARKINSONISM & RELATED DISORDERS
- NMDA antagonists for treating the non-motor symptoms in Parkinson’s disease
- (2018) Brigitte Vanle et al. Translational Psychiatry
- 18F-FPEB PET/CT Shows mGluR5 Upregulation in Parkinson's Disease
- (2018) Yeona Kang et al. JOURNAL OF NEUROIMAGING
- Genetic Knockdown of mGluR5 in Striatal D1R-Containing Neurons Attenuates l-DOPA-Induced Dyskinesia in Aphakia Mice
- (2018) José-Rubén García-Montes et al. MOLECULAR NEUROBIOLOGY
- NMDA receptor GluN2D subunit participates to levodopa-induced dyskinesia pathophysiology
- (2018) Manuela Mellone et al. NEUROBIOLOGY OF DISEASE
- The combination of the opioid glycopeptide MMP-2200 and a NMDA receptor antagonist reduced l-DOPA-induced dyskinesia and MMP-2200 by itself reduced dopamine receptor 2-like agonist-induced dyskinesia
- (2018) Andrew J. Flores et al. NEUROPHARMACOLOGY
- AMPA-induced extracellular Zn2+ influx into nigral dopaminergic neurons causes movement disorder in rats
- (2018) Haruna Tamano et al. NEUROTOXICOLOGY
- Enhanced AMPA receptor-mediated excitatory transmission in the rodent rostromedial tegmental nucleus following lesion of the nigrostriatal pathway
- (2018) Yongli Chang et al. NEUROCHEMISTRY INTERNATIONAL
- Discovery of VU2957 (Valiglurax): An mGlu4 Positive Allosteric Modulator Evaluated as a Preclinical Candidate for the Treatment of Parkinson’s Disease
- (2018) Joseph D. Panarese et al. ACS Medicinal Chemistry Letters
- Efficacy and safety of perampanel in Parkinson’s disease. A systematic review with meta-analysis
- (2017) Simona Lattanzi et al. JOURNAL OF NEUROLOGY
- Density of metabotropic glutamate receptors subtype 1 in Parkinson’s disease compared to healthy elderly – a ITMM PET study –
- (2017) M. Mishina et al. JOURNAL OF THE NEUROLOGICAL SCIENCES
- A Novel mglur4 compound alleviates motor symptoms in primate models of parkinson's disease
- (2017) D. Charvin et al. JOURNAL OF THE NEUROLOGICAL SCIENCES
- Trial of dextromethorphan/quinidine to treat levodopa-induced dyskinesia in Parkinson's disease
- (2017) Susan H. Fox et al. MOVEMENT DISORDERS
- Exciting Times: New Advances Towards Understanding the Regulation and Roles of Kainate Receptors
- (2017) Ashley J. Evans et al. NEUROCHEMICAL RESEARCH
- Metabotropic glutamate receptor 2 inhibits thalamically-driven glutamate and dopamine release in the dorsal striatum
- (2017) Kari A. Johnson et al. NEUROPHARMACOLOGY
- Development of a photoswitchable antagonist of NMDA receptors
- (2017) Felix W.W. Hartrampf et al. TETRAHEDRON
- Antiparkinsonian effects of the "Radiprodil and Tozadenant" combination in MPTP-treated marmosets
- (2017) Anne Michel et al. PLoS One
- A NMDA-receptor calcium influx assay sensitive to stimulation by glutamate and glycine/D-serine
- (2017) Hongqiu Guo et al. Scientific Reports
- The Role of Group II Metabotropic Glutamate Receptors in the Striatum in Electroacupuncture Treatment of Parkinsonian Rats
- (2016) Yan-Jun Jia et al. CNS Neuroscience & Therapeutics
- Ionotropic glutamate receptors: Which ones, when, and where in the mammalian neocortex
- (2016) Minela Hadzic et al. JOURNAL OF COMPARATIVE NEUROLOGY
- Dynamic Changes in Striatal mGluR1 But Not mGluR5 during Pathological Progression of Parkinson's Disease in Human Alpha-Synuclein A53T Transgenic Rats: A Multi-PET Imaging Study
- (2016) T. Yamasaki et al. JOURNAL OF NEUROSCIENCE
- Mavoglurant in Parkinson's patients withl-Dopa-induced dyskinesias: Two randomized phase 2 studies
- (2016) Claudia Trenkwalder et al. MOVEMENT DISORDERS
- A Phase 2A Trial of the Novel mGluR5-Negative Allosteric Modulator Dipraglurant for Levodopa-Induced Dyskinesia in Parkinson's Disease
- (2016) François Tison et al. MOVEMENT DISORDERS
- Long-term effect of sub-anesthetic ketamine in reducing l -DOPA-induced dyskinesias in a preclinical model
- (2016) Mitchell J. Bartlett et al. NEUROSCIENCE LETTERS
- Antidyskinetic Effect of 7-Nitroindazole and Sodium Nitroprusside Associated with Amantadine in a Rat Model of Parkinson’s Disease
- (2016) Mariza Bortolanza et al. NEUROTOXICITY RESEARCH
- Time and space profiling of NMDA receptor co-agonist functions
- (2015) Jean-Pierre Mothet et al. JOURNAL OF NEUROCHEMISTRY
- Adenosine A2Areceptors permit mGluR5-evoked tyrosine phosphorylation of NR2B (Tyr1472) in rat hippocampus: a possible key mechanism in NMDA receptor modulation
- (2015) Konstantinos Sarantis et al. JOURNAL OF NEUROCHEMISTRY
- Changes in glutamate receptors in dyskinetic parkinsonian monkeys after unilateral subthalamotomy
- (2015) Vincent A. Jourdain et al. JOURNAL OF NEUROSURGERY
- Pharmacological stimulation of metabotropic glutamate receptor type 4 in a rat model of Parkinson's disease and l-DOPA-induced dyskinesia: Comparison between a positive allosteric modulator and an orthosteric agonist
- (2015) Hanna Iderberg et al. NEUROPHARMACOLOGY
- The NR2B antagonist, ifenprodil, corrects the l-DOPA-induced deficit of bilateral movement and reduces c-Fos expression in the subthalamic nucleus of hemiparkinsonian rats
- (2015) Masakazu Igarashi et al. NEUROSCIENCE RESEARCH
- Behavioural Assessment of the A2a/NR2B Combination in the Unilateral 6-OHDA-Lesioned Rat Model: A New Method to Examine the Therapeutic Potential of Non-Dopaminergic Drugs
- (2015) Anne Michel et al. PLoS One
- Pathophysiology of L-dopa-induced motor and non-motor complications in Parkinson's disease
- (2015) Matthieu F. Bastide et al. PROGRESS IN NEUROBIOLOGY
- NMDA receptor GluN2A/GluN2B subunit ratio as synaptic trait of levodopa-induced dyskinesias: from experimental models to patients
- (2015) Manuela Mellone et al. Frontiers in Cellular Neuroscience
- The mGluR5 negative allosteric modulator dipraglurant reduces dyskinesia in the MPTP macaque model
- (2014) Erwan Bezard et al. MOVEMENT DISORDERS
- Parkin regulates kainate receptors by interacting with the GluK2 subunit
- (2014) AnnaMaria Maraschi et al. Nature Communications
- Stimulating ERK/PI3K/NFκB signaling pathways upon activation of mGluR2/3 restores OGD-induced impairment in glutamate clearance in astrocytes
- (2013) Chia-Ho Lin et al. EUROPEAN JOURNAL OF NEUROSCIENCE
- AFQ056 in Parkinson patients with levodopa-induced dyskinesia: 13-week, randomized, dose-finding study
- (2013) Fabrizio Stocchi et al. MOVEMENT DISORDERS
- Allosteric modulation of the group III mGlu4 receptor provides functional neuroprotection in the 6-hydroxydopamine rat model of Parkinson's disease
- (2012) Matthew J Betts et al. BRITISH JOURNAL OF PHARMACOLOGY
- Perampanel in Parkinson Disease Fluctuations
- (2012) Olivier Rascol et al. CLINICAL NEUROPHARMACOLOGY
- Glutamate Receptors as Therapeutic Targets for Parkinsons Disease
- (2012) Kari Johnson et al. CNS & Neurological Disorders-Drug Targets
- Synergy between l-DOPA and a novel positive allosteric modulator of metabotropic glutamate receptor 4: Implications for Parkinson's disease treatment and dyskinesia
- (2012) Khaled-Ezaheir Bennouar et al. NEUROPHARMACOLOGY
- Metabotropic glutamate receptor 5 antagonist protects dopaminergic and noradrenergic neurons from degeneration in MPTP-treated monkeys
- (2011) G. J. Masilamoni et al. BRAIN
- Defining protein kinase/phosphatase isoenzymic regulation of mGlu5receptor-stimulated phospholipase C and Ca2+responses in astrocytes
- (2011) SJ Bradley et al. BRITISH JOURNAL OF PHARMACOLOGY
- Perampanel, an AMPA antagonist, found to have no benefit in reducing “off” time in Parkinson's disease
- (2011) Andrew Lees et al. MOVEMENT DISORDERS
- The acute antiparkinsonian and antidyskinetic effect of AFQ056, a novel metabotropic glutamate receptor type 5 antagonist, in l-Dopa-treated parkinsonian monkeys
- (2011) Laurent Grégoire et al. PARKINSONISM & RELATED DISORDERS
- Reduction of L-DOPA-Induced Dyskinesia by the Selective Metabotropic Glutamate Receptor 5 Antagonist 3-[(2-Methyl-1,3-thiazol-4-yl)ethynyl]pyridine in the 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine-Lesioned Macaque Model of Parkinson's Disease
- (2010) T. H. Johnston et al. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
- Safety and efficacy of perampanel in advanced Parkinson's disease: A randomized, placebo-controlled study
- (2010) Karla Eggert et al. MOVEMENT DISORDERS
- Changes of AMPA receptors in MPTP monkeys with levodopa-induced dyskinesias
- (2010) B. Ouattara et al. NEUROSCIENCE
- Can we achieve neuroprotection with currently available anti-parkinsonian interventions?
- (2009) C. W. Olanow NEUROLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now